Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Todd Neale

February 18, 2025

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

Presentation THT 2023

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Presenter: NULL

March 22, 2023

News Conference News ESC 2022

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

Shelley Wood

September 01, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

Presentation TCT 2014

TCT 76: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute® Device in Patients with Ischemic Dilated Heart Failure: Primary Endpoint Results of the European Postmarket Trial - PARACHUTE III

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Ulrich Schaefer, MD

September 15, 2014

Advertisement

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

TCT 76: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute® Device in Patients with Ischemic Dilated Heart Failure: Primary Endpoint Results of the European Postmarket Trial - PARACHUTE III

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content